PATENT CLAIM ANALYSIS

Application Number: 16131985
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "171000"]

Abstract:
Provided herein are, inter alia, methods and compositions for treating cancer in a subject in need thereof comprising a therapeutically effective amount of a stilbenoid compound and a progestin.

Claim (Index 34):
The method of  claim 23 , wherein the endometrial cancer: (a) is Type I or Type II endometrial cancer; (b) is a carcinoma, an adenocarcinoma, a carcinosarcoma, or a mesenchymal tumor; (c) has a mucinous histology, a mixed histology or a undifferentiated histology, (d) is endometroid, serous, or clear-cell endometrial cancer; (e) is an endometrioid adenocarcinoma, an endometrioid carcinoma, a serous carcinoma, a clear cell carcinoma, a mucinous carcinoma, a mixed or undifferentiated carcinoma, a squamous cell carcinoma, a transitional cell carcinoma, or a endometrial stromal sarcoma, (f) is recurrent endometrial cancer, or (g) is Stage 0, Stage IA, IB, II, IIA, IIIA, IIIB, IIIC1, IIIC2, IVA or IVB endometrial cancer.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.23077
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15508391', '13690920', '13453778', '13453789', '14779276']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7243529709736746
- 35 USC 102 Novelty (BERT): 0.5115376746267408
- Combined Prediction Score: 0.7030714413389813
- Mean Citation Score: 258.61701400000004
- Max Citation Score: 267.27695
- Similarity Product: 182.1797698362797

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test